More grim than the shortage of experts are the unmet challenges while facing the situation 1) lack of a uniform pattern of ROP screening, 2) lack of collaboration between the neonatologists, pediatricians, and ophthalmologists, 3) lack of collaboration between the private and public sector, 4) unsolved medicolegal aspects relating to timely screening, appropriate follow-up and treatment, 5) lack of uniform guidelines for intravitreal anti vascular endothelial growth factor injections, and 6) lack of a roadmap and resources for long-term follow-up of these ROP graduates.
This special edition of the Indian Journal of Ophthalmology puts together efforts to address few of these challenges. From community-based data [3] to newer methods of screening, [4] the manuscripts make a significant contribution to bringing evidence to the practice of ROP care.
As the iROP society continues to impact work in India, it has expanded its influence in initiating the Asia Retinopathy of Prematurity Working Group in March 2019, with the aim of sharing experiences, collaborating resources, and unifying practice patterns. The operational guidelines for ROP screening that the National Task Force for ROP in India released in 2018 has already become popular in other nations in the Indian subcontinent and beyond.
[5] With common disease demographics and lack of resources, we must break barriers and cross borders to effectively tackle the scourge of ROP.
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